Litcius/Paper detail

Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial

Hamid Rahmani, Effat Davoudi-Monfared, Anahid Nourian, Hossein Khalili, Nooshin Hajizadeh, Narjes Zarei Jalalabadi, Mohammad Reza Fazeli, Monireh Ghazaeian, Mir Saeed Yekaninejad

2020International Immunopharmacology158 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Randomized controlled trialMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)InterferonBetacoronavirusClinical trialPandemicVirologyIntensive care medicineInternal medicineOutbreakDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial | Litcius